{
    "clinical_study": {
        "@rank": "95814", 
        "arm_group": [
            {
                "arm_group_label": "3M CHG/IPA Colorless", 
                "arm_group_type": "Experimental", 
                "description": "Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% 10.5 mL applicator"
            }, 
            {
                "arm_group_label": "3M CHG/IPA Tint", 
                "arm_group_type": "Experimental", 
                "description": "Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% 10.5 mL applicator"
            }, 
            {
                "arm_group_label": "ChloraPrep CHG/IPA Hi-Lite Orange Tint", 
                "arm_group_type": "Active Comparator", 
                "description": "Chlorhexidine (CHG) 2% / Isopropyl alcohol (IPA) 70% 10.5 mL applicator"
            }, 
            {
                "arm_group_label": "Normal Saline", 
                "arm_group_type": "Placebo Comparator", 
                "description": "0.9% normal saline with applicator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the antimicrobial efficacy of the 3M CHG/IPA Prep\n      on skin flora of the abdomen and inguinal regions of human subjects."
        }, 
        "brief_title": "In-vivo Efficacy Study of Patient Preoperative Preps", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Bacterial Reduction on Subject Skin Flora Post-product Application.", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects of any race\n\n          -  Subjects in good general health\n\n          -  Minimum skin flora baseline requirements on abdomen and groin\n\n        Exclusion Criteria:\n\n          -  Any tattoos, scars, breaks in the skin, or any form of dermatitis, or other skin\n             disorders (including acne) on the applicable test areas\n\n          -  Topical antimicrobial exposure within 14 days prior to screening and treatment days\n\n          -  Use of systemic or topical antibiotics, steroid medications, or any other products\n             known to affect the normal microbial flora of the skin within 14 days prior to\n             screening and treatment days"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "419", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 21, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01968356", 
            "org_study_id": "EM-012759"
        }, 
        "intervention": {
            "arm_group_label": [
                "3M CHG/IPA Colorless", 
                "3M CHG/IPA Tint", 
                "ChloraPrep CHG/IPA Hi-Lite Orange Tint", 
                "Normal Saline"
            ], 
            "intervention_name": "CHG 2% / IPA 70%", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "surgical skin prep", 
            "CHG", 
            "IPA"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bozeman", 
                    "country": "United States", 
                    "state": "Montana", 
                    "zip": "59718"
                }, 
                "name": "BioScience Laboratories, Inc."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Assessment of the Antimicrobial Efficacy of 3M CHG/IPA Preoperative Skin Preparation Against Resident Human Skin Flora on the Abdominal and Inguinal Regions", 
        "overall_official": {
            "affiliation": "BioScience Laboratories, Inc.", 
            "last_name": "Robert R McCormack, BS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "A 2-log per cm2 bacterial reduction on the abdomen region and a 3-log per cm2 bacterial reduction on the inguinal region.", 
                "safety_issue": "No", 
                "time_frame": "10 minutes post-product application"
            }, 
            {
                "measure": "Skin flora does not return to baseline on the abdomen and inguinal region.", 
                "safety_issue": "No", 
                "time_frame": "6 hour post-product application"
            }, 
            {
                "measure": "Safety as assessed by Skin Irritation scores and Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "10 minute to 6 hours post-product application"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01968356"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "3M", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "3M", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014", 
        "why_stopped": "Study discontinued due to data quality issues."
    }
}